Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ETAccesswire • 04/30/24
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024Accesswire • 04/09/24
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in LiquidityAccesswire • 04/01/24
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ETAccesswire • 03/20/24
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) PlatformAccesswire • 03/14/24
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary ConferencesAccesswire • 03/12/24
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working DogsAccesswire • 03/07/24
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health ConferencesAccesswire • 02/08/24
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)Accesswire • 02/06/24
Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock SplitAccesswire • 01/25/24
Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")Accesswire • 01/17/24
Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of ShareholAccesswire • 01/10/24
Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel “X-Trode” HandpieceAccesswire • 01/04/24